Angco, Alliyah Marly M.
HRN: 23-54-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
08/21/2023
08/28/2023
ORAL
3ml
Q12
PCAP
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes